Landscapes / Companies
Salubris Biotherapeutics Inc not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
Drugs
2
in active trials · 3 in all
Trials
2 active
6 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 1 Apr 2028Phase 1/2 trial completes | |||
| Next date | 1 Apr 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction | ||||
| Open drug page | |||||
About
- No active trial
- JK08
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021